Global Equine Artificial Insemination 麻豆原创 Research Report 2024

Publication ID:

PB507246475

Publication Date:

July 19, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Agriculture [2]

Industry & Manufacturing [3]

Description:

Breeding organizations have been exchanging large amounts of breeding stock internationally for many years. Significant advancements in reproduction methods, including the use of refrigerated and frozen semen, have made it possible for breeding stallions to be used concurrently in several nations. While countries with small populations frequently import breeding stock, those with large sport horse populations, like Germany and France, frequently export sport horses. Horse breeds are chosen based on the animal's ancestry, athletic accomplishments, and temperament. The cost of a stallion's sperm is the deciding factor when selecting a sire. Moreover, the sexing of sperm, low-dose deep intrauterine insemination, and intracytoplasmic sperm injection are recent developments in horse insemination.
The global Equine Artificial Insemination market was valued at US$ 636.1 million in 2023 and is anticipated to reach US$ 910.7 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The equine artificial insemination (AI) market growth is further driven due to the presence of institutions with advanced levels of training, research into new technologies and procedures, and progress in the field of horse reproduction.
This report aims to provide a comprehensive presentation of the global market for Equine Artificial Insemination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Artificial Insemination.
Report Scope
The Equine Artificial Insemination market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Equine Artificial Insemination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Artificial Insemination companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Continental Genetics, LLC
CVS (UK) Limited.
ERC S.r.o.
HOFFMAN A.I. BREEDERS INC.
IMV Technologie
MINITUB GMBH
Nasco
Neogen Corporation
Stallion AI Services
Sussex Equine Hospital
Zerlotti Genetics Ltd
Zoetis
Segment by Type
Equipment & Consumables
Semen
Services
Segment by Application
Sports/Racing
Recreation
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Equine Artificial Insemination companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Equine Artificial Insemination 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Equipment & Consumables
1.2.3 Semen
1.2.4 Services
1.3 麻豆原创 by Application
1.3.1 Global Equine Artificial Insemination 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Sports/Racing
1.3.3 Recreation
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Equine Artificial Insemination 麻豆原创 Perspective (2019-2030)
2.2 Equine Artificial Insemination Growth Trends by Region
2.2.1 Global Equine Artificial Insemination 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Equine Artificial Insemination Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Equine Artificial Insemination Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Equine Artificial Insemination 麻豆原创 Dynamics
2.3.1 Equine Artificial Insemination Industry Trends
2.3.2 Equine Artificial Insemination 麻豆原创 Drivers
2.3.3 Equine Artificial Insemination 麻豆原创 Challenges
2.3.4 Equine Artificial Insemination 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Equine Artificial Insemination Players by Revenue
3.1.1 Global Top Equine Artificial Insemination Players by Revenue (2019-2024)
3.1.2 Global Equine Artificial Insemination Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Equine Artificial Insemination 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Equine Artificial Insemination Revenue
3.4 Global Equine Artificial Insemination 麻豆原创 Concentration Ratio
3.4.1 Global Equine Artificial Insemination 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Equine Artificial Insemination Revenue in 2023
3.5 Equine Artificial Insemination Key Players Head office and Area Served
3.6 Key Players Equine Artificial Insemination Product Solution and Service
3.7 Date of Enter into Equine Artificial Insemination 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Equine Artificial Insemination Breakdown Data by Type
4.1 Global Equine Artificial Insemination Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Equine Artificial Insemination Forecasted 麻豆原创 Size by Type (2025-2030)
5 Equine Artificial Insemination Breakdown Data by Application
5.1 Global Equine Artificial Insemination Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Equine Artificial Insemination Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Equine Artificial Insemination 麻豆原创 Size (2019-2030)
6.2 North America Equine Artificial Insemination 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Equine Artificial Insemination 麻豆原创 Size by Country (2019-2024)
6.4 North America Equine Artificial Insemination 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Equine Artificial Insemination 麻豆原创 Size (2019-2030)
7.2 Europe Equine Artificial Insemination 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Equine Artificial Insemination 麻豆原创 Size by Country (2019-2024)
7.4 Europe Equine Artificial Insemination 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Equine Artificial Insemination 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Equine Artificial Insemination 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Equine Artificial Insemination 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Equine Artificial Insemination 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Equine Artificial Insemination 麻豆原创 Size (2019-2030)
9.2 Latin America Equine Artificial Insemination 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Equine Artificial Insemination 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Equine Artificial Insemination 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Equine Artificial Insemination 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Equine Artificial Insemination 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Equine Artificial Insemination 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Equine Artificial Insemination 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Continental Genetics, LLC
11.1.1 Continental Genetics, LLC Company Detail
11.1.2 Continental Genetics, LLC Business Overview
11.1.3 Continental Genetics, LLC Equine Artificial Insemination Introduction
11.1.4 Continental Genetics, LLC Revenue in Equine Artificial Insemination Business (2019-2024)
11.1.5 Continental Genetics, LLC Recent Development
11.2 CVS (UK) Limited.
11.2.1 CVS (UK) Limited. Company Detail
11.2.2 CVS (UK) Limited. Business Overview
11.2.3 CVS (UK) Limited. Equine Artificial Insemination Introduction
11.2.4 CVS (UK) Limited. Revenue in Equine Artificial Insemination Business (2019-2024)
11.2.5 CVS (UK) Limited. Recent Development
11.3 ERC S.r.o.
11.3.1 ERC S.r.o. Company Detail
11.3.2 ERC S.r.o. Business Overview
11.3.3 ERC S.r.o. Equine Artificial Insemination Introduction
11.3.4 ERC S.r.o. Revenue in Equine Artificial Insemination Business (2019-2024)
11.3.5 ERC S.r.o. Recent Development
11.4 HOFFMAN A.I. BREEDERS INC.
11.4.1 HOFFMAN A.I. BREEDERS INC. Company Detail
11.4.2 HOFFMAN A.I. BREEDERS INC. Business Overview
11.4.3 HOFFMAN A.I. BREEDERS INC. Equine Artificial Insemination Introduction
11.4.4 HOFFMAN A.I. BREEDERS INC. Revenue in Equine Artificial Insemination Business (2019-2024)
11.4.5 HOFFMAN A.I. BREEDERS INC. Recent Development
11.5 IMV Technologie
11.5.1 IMV Technologie Company Detail
11.5.2 IMV Technologie Business Overview
11.5.3 IMV Technologie Equine Artificial Insemination Introduction
11.5.4 IMV Technologie Revenue in Equine Artificial Insemination Business (2019-2024)
11.5.5 IMV Technologie Recent Development
11.6 MINITUB GMBH
11.6.1 MINITUB GMBH Company Detail
11.6.2 MINITUB GMBH Business Overview
11.6.3 MINITUB GMBH Equine Artificial Insemination Introduction
11.6.4 MINITUB GMBH Revenue in Equine Artificial Insemination Business (2019-2024)
11.6.5 MINITUB GMBH Recent Development
11.7 Nasco
11.7.1 Nasco Company Detail
11.7.2 Nasco Business Overview
11.7.3 Nasco Equine Artificial Insemination Introduction
11.7.4 Nasco Revenue in Equine Artificial Insemination Business (2019-2024)
11.7.5 Nasco Recent Development
11.8 Neogen Corporation
11.8.1 Neogen Corporation Company Detail
11.8.2 Neogen Corporation Business Overview
11.8.3 Neogen Corporation Equine Artificial Insemination Introduction
11.8.4 Neogen Corporation Revenue in Equine Artificial Insemination Business (2019-2024)
11.8.5 Neogen Corporation Recent Development
11.9 Stallion AI Services
11.9.1 Stallion AI Services Company Detail
11.9.2 Stallion AI Services Business Overview
11.9.3 Stallion AI Services Equine Artificial Insemination Introduction
11.9.4 Stallion AI Services Revenue in Equine Artificial Insemination Business (2019-2024)
11.9.5 Stallion AI Services Recent Development
11.10 Sussex Equine Hospital
11.10.1 Sussex Equine Hospital Company Detail
11.10.2 Sussex Equine Hospital Business Overview
11.10.3 Sussex Equine Hospital Equine Artificial Insemination Introduction
11.10.4 Sussex Equine Hospital Revenue in Equine Artificial Insemination Business (2019-2024)
11.10.5 Sussex Equine Hospital Recent Development
11.11 Zerlotti Genetics Ltd
11.11.1 Zerlotti Genetics Ltd Company Detail
11.11.2 Zerlotti Genetics Ltd Business Overview
11.11.3 Zerlotti Genetics Ltd Equine Artificial Insemination Introduction
11.11.4 Zerlotti Genetics Ltd Revenue in Equine Artificial Insemination Business (2019-2024)
11.11.5 Zerlotti Genetics Ltd Recent Development
11.12 Zoetis
11.12.1 Zoetis Company Detail
11.12.2 Zoetis Business Overview
11.12.3 Zoetis Equine Artificial Insemination Introduction
11.12.4 Zoetis Revenue in Equine Artificial Insemination Business (2019-2024)
11.12.5 Zoetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Continental Genetics, LLC
CVS (UK) Limited.
ERC S.r.o.
HOFFMAN A.I. BREEDERS INC.
IMV Technologie
MINITUB GMBH
Nasco
Neogen Corporation
Stallion AI Services
Sussex Equine Hospital
Zerlotti Genetics Ltd
Zoetis

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.